Moneycontrol PRO
you are here: HomeNewsOpinion

Serum Institute gets ahead in COVID-19 vaccine, but opportunity still exists for others

Serum Institute alone cannot inoculate the entire population at one go. This leaves enough space for competitor vaccines, provided they succeed in clinical trials

January 06, 2021 / 11:13 AM IST
Serum Institute gets ahead in COVID-19 vaccine, but opportunity still exists for others

Close to 8 million frontline workers have already registered under the Co-WIN app to get inoculated. (Source: Reuters)

The approval for Serum Institute of India and Bharat Biotech’s COVID-19 vaccines raises questions about the immunisation business potential for others. Several companies including Dr Reddy’s Laboratories Ltd, Aurobindo Pharma Ltd, Cadila Healthcare Ltd, and Biological E Ltd are at various stages of developing a vaccine for COVID-19. Serum Institute in partnership with Novavax is also developing another vaccine. Of the two that have received emergency approval, Serum Institute’s Covishield is backed by AstraZeneca/Oxford University technology and has supportive efficacy data (though...

  • PRO Panorama

    Moneycontrol Pro Panorama | Robinhood missed the mark on a bumper listing

    Jul 30, 2021 / 04:26 PM IST

    In today’s edition of Moneycontrol Pro Panorama:  Why Robinhood stumbled, the problem with IMF forecasts, the Immunity Tracker, Tech Mahindra’s growth appeal, Tactical Pick, the Indian startup rage, China pushes back on crypto and more  

    Read Now

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers